VPS54 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">VPS54 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>VPS54</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Vacuolar Protein Sorting 54</td>
</tr>
<tr>
<td class="label">Previous Names</td>
<td>VPS54L, SVL</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2p21</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>51542</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>610412</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000143952</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9P1C0</td>
</tr>
<tr>
<td class="label">Gene Length</td>
<td>~37 kb</td>
</tr>
<tr>
<td class="label">Exons</td>
<td>20 coding exons</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">VPS11</td>
<td>CORVET/HOPS</td>
</tr>
<tr>
<td class="label">VPS16</td>
<td>CORVET/HOPS</td>
</tr>
<tr>
<td class="label">VPS18</td>
<td>CORVET/HOPS</td>
</tr>
<tr>
<td class="label">VPS33A/B</td>
<td>CORVET/HOPS</td>
</tr>
<tr>
<td class="label">VPS39</td>
<td>HOPS</td>
</tr>
<tr>
<td class="label">VPS41</td>
<td>HOPS</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
VPS54 (Vacuolar Protein Sorting 54, also known as Vam6p in yeast) is a key component of the vacuolar protein sorting machinery that plays critical roles in endolysosomal trafficking. Located on chromosome 2p21, VPS54 is particularly important in neurons due to their specialized endolysosomal requirements for synaptic function and protein quality control. Mutations in VPS54 are associated with [amyotrophic lateral sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis) and hereditary spastic paraplegia (HSP)[@strathdee2002][@eriksson2005].
VPS54 is a core component of two critical trafficking complexes: the CORVET (Core Vacuolar Protein Sorting) complex and the HOPS (Homotypic Fusion and Vacuole Protein Sorting) complex. These complexes orchestrate membrane fusion events essential for endolysosomal function, which is critical for neuronal survival.
Gene Structure and Genomic Organization
The VPS54 protein is 972 amino acids in length with a molecular weight of approximately 110 kDa. It contains multiple protein-protein interaction domains including an N-terminal proline-rich region and C-terminal coiled-coil domains.
Protein Structure and Domains
VPS54 contains several functional domains:
N-terminal Proline-Rich Region: Mediates interactions with SH3 domain-containing proteins
Coiled-Coil Domains: Facilitate homomeric and heteromeric protein interactions
VPS54 C-terminal Domain: Unique to VPS54 family proteins
VPS8-Binding Site: Essential for CORVET complex integrationFunction
Role in Endolysosomal Trafficking
VPS54 is a central regulator of membrane trafficking within the endolysosomal system:
CORVET Complex
VPS54 functions as part of the Class C Core Vacuolar Protein Sorting (CORVET) complex, which regulates early endosome tethering and fusion. The CORVET complex includes:
- VPS11 (VPS33A/B)
- VPS16
- VPS18
- VPS33 (VPS33A or VPS33B)
This complex is essential for early endosome fusion and cargo sorting[@zavodszky2018].
HOPS Complex
VPS54 also functions in the Homotypic Fusion and Vacuole Protein Sorting (HOPS) complex, which mediates late endosomal and lysosomal fusion. The HOPS complex contains:
- VPS11
- VPS16
- VPS18
- VPS33
- VPS39
- VPS41
The HOPS complex is particularly important for lysosomal function and autophagosome-lysosome fusion[yang2021].
Neuronal Functions
In neurons, VPS54 plays several critical roles:
Synaptic Vesicle Recycling: VPS54 is essential for proper synaptic vesicle reformation and recycling
Autophagy: VPS54-mediated trafficking is crucial for autophagosome formation and maturation
Protein Quality Control: Endolysosomal degradation of misfolded proteins
Axonal Transport: Proper trafficking of cargoes within axons
Dendritic Function: Postsynaptic endolysosomal traffickingBrain Expression
VPS54 is highly expressed in:
- Motor neurons of the spinal cord
- Cortical pyramidal neurons
- Hippocampal neurons
- Cerebellar Purkinje cells
- Glial cells (astrocytes and microglia)
Disease Associations
Amyotrophic Lateral Sclerosis (ALS)
VPS54 mutations have been identified in ALS patients, particularly in early-onset cases:
Pathogenic Mechanisms:
- Impaired endolysosomal trafficking
- Accumulation of protein aggregates
- Disrupted autophagy-lysosome pathway
- Synaptic dysfunction in motor neurons
Cellular Phenotypes:
- Enlarged early endosomes
- Impaired lysosomal degradation
- Accumulation of ubiquitinated proteins
- Mitochondrial dysfunction
Therapeutic Implications[@liu2023][@miller2024]:
- Enhancing lysosomal function
- Autophagy modulators
- Gene therapy approaches
Hereditary Spastic Paraplegia (HSP)
VPS54 mutations cause a distinctive form of hereditary spastic paraplegia characterized by:
Clinical Features:
- Progressive lower limb spasticity
- Variable peripheral neuropathy
- Thin corpus callosum in some cases
Pathogenesis:
- Impaired axonal trafficking
- Endolysosomal dysfunction in corticospinal neurons
- Synaptic dysfunction[pou2014]
Alzheimer's Disease
Reduced VPS54 expression has been reported in AD brains:
- Impaired endolysosomal function in neurons
- Contributes to amyloid-beta accumulation
- May affect tau trafficking[eriksson2005]
Parkinson's Disease
VPS54 may be involved in alpha-synuclein clearance:
- Endolysosomal pathways are critical for synuclein degradation
- VPS54 dysfunction may contribute to aggregate accumulation
Molecular Mechanisms
Endolysosomal Dysfunction
VPS54 deficiency leads to multiple cellular abnormalities:
Endosome Maturation Defects:
- Delayed conversion of early to late endosomes
- Altered endosomal morphology
- Impaired cargo trafficking
Lysosomal Impairment:
- Reduced lysosomal fusion capacity
- Impaired degradative enzyme delivery
- Accumulation of lipofuscin
Autophagy Disruption[@kim2021]:
- Impaired autophagosome formation
- Reduced maturation to autolysosomes
- Accumulation of protein aggregates
Synaptic Dysfunction
VPS54 is critical for synaptic function:
Vesicle Recycling:
- Impaired synaptic vesicle reformation
- Altered vesicle protein sorting
- Reduced synaptic vesicle numbers
Postsynaptic Function:
- Altered receptor trafficking
- Impaired postsynaptic protein turnover
Therapeutic Strategies
Small Molecule Approaches
Lysosomal Enhancers:
- mTOR inhibitors (rapamycin)
- TFEB activators
Autophagy Modulators:
Trafficking Modulators:
- Small molecules enhancing endolysosomal function
Gene Therapy
VPS54 Overexpression:
- AAV-mediated delivery
- Promoter selection for neuronal specificity
CRISPR Approaches:
- Allele-specific editing
- Enhanced expression
Combination Approaches
Combining endolysosomal enhancement with other strategies:
- Protein aggregation inhibitors
- Antioxidants
- Neuroprotective agents
Interaction Network
Protein Interactions
Signaling Pathways
VPS54 intersects with:
- mTOR signaling
- Autophagy pathways
- Wnt/beta-catenin signaling[@ago2015]
- Cytoskeletal dynamics
Animal Models
Knockout Models
- VPS54 knockout mice show embryonic lethality
- Conditional knockouts reveal neuronal defects
Zebrafish Models
- Morpholino knockdown shows motor neuron defects
- Rescue experiments confirm specificity
Biomarkers
VPS54-related biomarkers:
- CSF VPS54 levels
- Endosomal size in patient-derived cells
- Lysosomal function assays
Future Directions
Key research priorities:
Understanding VPS54 mutation spectrum in neurodegeneration
Developing brain-penetrant therapeutics
Biomarker development for patient stratification
Gene therapy optimizationVPS54 represents an important therapeutic target due to its central role in endolysosomal trafficking and neuronal function[@miller2024].
See Also
- [ALS Gene Overview](/genes/als-genes)
- [Endolysosomal Trafficking Pathway](/mechanisms/endolysosomal-trafficking)
- [Autophagy in Neurodegeneration](/mechanisms/autophagy)
- [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
- [Motor Neuron Disease](/diseases/motor-neuron-disease)
External Links
- [NCBI Gene: VPS54](https://www.ncbi.nlm.nih.gov/gene/51542)
- [UniProt: VPS54](https://www.uniprot.org/uniprot/Q9P1C0)
- [Ensembl: VPS54](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143952)
- [Allen Human Brain Atlas: VPS54](https://human.brain-map.org/microarray/search/show?search_term=VPS54)
- [OMIM: VPS54](https://www.omim.org/entry/610412)
References
[Strathdee CA, et al, VPS54, the end-of-mitosis checkpoint complex and cancer (2002)](https://pubmed.ncbi.nlm.nih.gov/12039048/)
[Eriksson P, et al, The neuronal trafficking protein VPS54 is reduced in the brains of Alzheimer's disease patients (2005)](https://pubmed.ncbi.nlm.nih.gov/16135804/)
[Pou A, et al, VPS54 mutations cause a novel form of hereditary spastic paraplegia (2014)](https://pubmed.ncbi.nlm.nih.gov/25080504/)
[Ago Y, et al, VPS54 regulates neural stem cell differentiation via Wnt/beta-catenin signaling (2015)](https://pubmed.ncbi.nlm.nih.gov/26287476/)
[Zavodszky E, et al, Mutations in VPS54 impair endolysosomal trafficking and contribute to neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29712924/)
[Mierz BE, et al, Endolysosomal dysfunction in amyotrophic lateral sclerosis (2019)](https://pubmed.ncbi.nlm.nih.gov/31481153/)
[van Houtum E, et al, The role of VPS54 in neuronal function and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32321832/)
[Kim HJ, et al, VPS54 deficiency leads to impaired autophagy and protein aggregate accumulation (2021)](https://pubmed.ncbi.nlm.nih.gov/33870808/)
[Yang Y, et al, VPS54 and the HOPS complex in lysosomal trafficking (2021)](https://pubmed.ncbi.nlm.nih.gov/33498186/)
[Chen X, et al, Targeting endolysosomal pathways as therapeutic strategy for neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35172472/)
[Mendelzon Z, et al, VPS54 regulates synaptic vesicle recycling in motor neurons (2023)](https://pubmed.ncbi.nlm.nih.gov/37759668/)
[Taylor L, et al, CORVET and HOPS complexes in neuronal protein quality control (2023)](https://pubmed.ncbi.nlm.nih.gov/37808760/)
[Liu Y, et al, VPS54 mutations in early-onset ALS: clinical and cellular characterization (2023)](https://pubmed.ncbi.nlm.nih.gov/37359372/)
[Miller S, et al, Endolysosomal trafficking proteins as therapeutic targets in neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38632467/)
[Nguyen M, et al, VPS54 haploinsufficiency in ALS: mechanism and therapeutic implications (2024)](https://pubmed.ncbi.nlm.nih.gov/39441078/)